On Halloween, Lexicon was haunted again as an FDA advisory committee voted 11-3 to reject Zynquista as an accompanying ...

Diabetes is one of the most common chronic conditions worldwide, impacting millions of individuals. While it requires ...

Committee members said there was uncertainty around sotagliflozin in patients with kidney disease. The FDA is currently ...

Lexicon did manage to get approval for type 1 diabetes in Europe, but the product was never launched there for commercial ...

Lexicon Pharmaceuticals shares have been halted all day as a Food and Drug Administration advisory committee was scheduled to vote on Zynquista as an adjunct to insulin therapy for glycemic control in ...

Lexicon Pharmaceuticals received a negative vote from a Food and Drug Administration advisory committee for Zynquista as an adjunct to insulin therapy for glycemic control in adults with Type 1 ...

Dr Jokotade Adeleye, a consultant endocrinologist at the University College Hospital (UCH), Ibadan, in this interview with SADE OGUNTOLA, speaks on the importance of regular blood glucose monitoring ...

FDA staff raised familiar safety concerns about sotagliflozin as a treatment for type 1 diabetes (T1D) as the agency again ...

The Rio Grande Valley has elevated rates of diabetes, heart failure and other chronic conditions ... Singh died of diabetes ...

The Rio Grande Valley has elevated rates of diabetes, heart failure and other chronic ... Singh died of diabetes ketoacidosis (DKA), complicated by heat exposure. DKA develops when the body ...